Does the media refer more to VANI or COCH?

In the previous week, Vivani Medical and Vivani Medical both had 1 articles in the media. Vivani Medical's average media sentiment score of 0.75 equaled Envoy Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is STIM or COCH more profitable?

Neuronetics has a net margin of -19.62% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -19.62% -125.11% -22.15% Envoy Medical -11,304.83% N/A -144.13%

Is COCH or FOCL more profitable?

FocalTherics has a net margin of -56.26% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets Envoy Medical -11,304.83% N/A -144.13% FocalTherics -56.26% -248.00% -44.69%

Does the media favor COCH or FOCL?

In the previous week, Envoy Medical and Envoy Medical both had 1 articles in the media. FocalTherics' average media sentiment score of 1.02 beat Envoy Medical's score of 0.75 indicating that FocalTherics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FocalTherics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, OWLT or COCH?

Envoy Medical has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.40 -$39.68M -$0.75 N/A Envoy Medical $207K 242.77 -$23.76M -$0.76 N/A

Is OWLT or COCH more profitable?

Owlet has a net margin of -8.61% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Envoy Medical -11,304.83% N/A -144.13%

Does the media favor OWLT or COCH?

In the previous week, Owlet and Owlet both had 1 articles in the media. Owlet's average media sentiment score of 1.97 beat Envoy Medical's score of 0.75 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ZJYL or COCH?

Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 207.22%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Envoy Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, ZJYL or COCH?

Jin Medical International has higher revenue and earnings than Envoy Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $19.73M 7.87 $1.19M N/A N/A Envoy Medical $207K 242.77 -$23.76M -$0.76 N/A

Is ZJYL or COCH more profitable?

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Company Net Margins Return on Equity Return on Assets Jin Medical International N/A N/A N/A Envoy Medical -11,304.83% N/A -144.13%

Envoy Medical (COCH) Competitors

$0.65 -0.03 (-3.98%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$0.66 +0.00 (+0.61%)

As of 10/5/2026 07:17 PM Eastern

Compare

COCH vs. VANI, STIM, FOCL, OWLT, and ZJYL

Should you buy Envoy Medical stock or one of its competitors? Envoy Medical's main competitors and comparable companies include Vivani Medical (VANI), Neuronetics (STIM), FocalTherics (FOCL), Owlet (OWLT), and Jin Medical International (ZJYL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Envoy Medical compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-191.05%	-70.91%
Envoy Medical	-11,304.83%	N/A	-144.13%

Vivani Medical has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market.

In the previous week, Vivani Medical and Vivani Medical both had 1 articles in the media. Vivani Medical's average media sentiment score of 0.75 equaled Envoy Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.35	N/A
Envoy Medical	$207K	242.77	-$23.76M	-$0.76	N/A

Vivani Medical currently has a consensus target price of $3.75, suggesting a potential upside of 207.38%. Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 207.22%. Given Vivani Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Vivani Medical is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 7.2% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Vivani Medical beats Envoy Medical on 8 of the 13 factors compared between the two stocks.

How does Envoy Medical compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 8.4% of Neuronetics shares are held by insiders. Comparatively, 7.2% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Neuronetics has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, suggesting that its stock price is 97% more volatile than the broader market.

Neuronetics currently has a consensus target price of $4.67, suggesting a potential upside of 112.12%. Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 207.22%. Given Envoy Medical's higher probable upside, analysts plainly believe Envoy Medical is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Neuronetics has a net margin of -19.62% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Envoy Medical	-11,304.83%	N/A	-144.13%

In the previous week, Envoy Medical had 1 more articles in the media than Neuronetics. MarketBeat recorded 1 mentions for Envoy Medical and 0 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.76 beat Envoy Medical's score of 0.75 indicating that Neuronetics is being referred to more favorably in the media.

Company	Overall Sentiment
Neuronetics	Positive
Envoy Medical	Positive

Envoy Medical has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$155.10M	1.08	-$39M	-$0.44	N/A
Envoy Medical	$207K	242.77	-$23.76M	-$0.76	N/A

Summary

Neuronetics beats Envoy Medical on 9 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to FocalTherics?

Envoy Medical (NASDAQ:COCH) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

Envoy Medical currently has a consensus price target of $2.00, suggesting a potential upside of 207.22%. FocalTherics has a consensus price target of $7.75, suggesting a potential upside of 83.22%. Given Envoy Medical's higher possible upside, equities research analysts clearly believe Envoy Medical is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

FocalTherics has a net margin of -56.26% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
FocalTherics	-56.26%	-248.00%	-44.69%

Envoy Medical has higher earnings, but lower revenue than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$207K	242.77	-$23.76M	-$0.76	N/A
FocalTherics	$70.53M	2.25	-$29.25M	-$1.03	N/A

Envoy Medical has a beta of 1.97, suggesting that its share price is 97% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market.

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Comparatively, 10.1% of FocalTherics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Envoy Medical and Envoy Medical both had 1 articles in the media. FocalTherics' average media sentiment score of 1.02 beat Envoy Medical's score of 0.75 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
FocalTherics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

FocalTherics beats Envoy Medical on 8 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Owlet?

Owlet (NYSE:OWLT) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Owlet and Owlet both had 1 articles in the media. Owlet's average media sentiment score of 1.97 beat Envoy Medical's score of 0.75 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envoy Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envoy Medical has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.40	-$39.68M	-$0.75	N/A
Envoy Medical	$207K	242.77	-$23.76M	-$0.76	N/A

Owlet has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market.

72.6% of Owlet shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Owlet has a net margin of -8.61% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Envoy Medical	-11,304.83%	N/A	-144.13%

Owlet currently has a consensus price target of $15.00, indicating a potential upside of 195.86%. Envoy Medical has a consensus price target of $2.00, indicating a potential upside of 207.22%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Owlet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Owlet beats Envoy Medical on 9 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

Jin Medical International has a beta of 7.4, meaning that its stock price is 640% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market.

Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 207.22%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Jin Medical International has higher revenue and earnings than Envoy Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$19.73M	7.87	$1.19M	N/A	N/A
Envoy Medical	$207K	242.77	-$23.76M	-$0.76	N/A

8.6% of Envoy Medical shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Envoy Medical had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for Envoy Medical and 0 mentions for Jin Medical International. Envoy Medical's average media sentiment score of 0.75 beat Jin Medical International's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Jin Medical International	Neutral
Envoy Medical	Positive

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Envoy Medical	-11,304.83%	N/A	-144.13%

Summary

Envoy Medical beats Jin Medical International on 8 of the 13 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$52.34M	$5.46B	$7.14B	$13.26B
Dividend Yield	N/A	1.79%	2.53%	17.36%
P/E Ratio	-0.86	25.76	274.32	26.20
Price / Sales	242.77	69.14	609.24	88.33
Price / Cash	N/A	32.73	27.22	34.70
Price / Book	-1.55	6.04	11.23	6.40
Net Income	-$23.76M	$146.97M	$3.49B	$381.07M
7 Day Performance	-8.18%	-0.46%	-1.31%	-0.28%
1 Month Performance	-8.31%	-4.28%	-5.97%	-4.51%
1 Year Performance	-19.31%	2.07%	7.26%	1.63%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.5057 of 5 stars	$0.65 -4.0%	$2.00 +207.2%	-20.0%	$52.34M	$207K	N/A	47	Positive News
VANI Vivani Medical	2.3847 of 5 stars	$1.25 +1.5%	$3.75 +200.2%	-12.9%	$112.66M	N/A	N/A	36	Positive News
STIM Neuronetics	4.2827 of 5 stars	$2.34 -0.8%	$4.67 +99.4%	-22.8%	$178.30M	$155.10M	N/A	658	Positive News
FOCL FocalTherics	4.5946 of 5 stars	$4.47 -1.5%	$7.75 +73.4%	N/A	$167.75M	$79.31M	N/A	230	Positive News
OWLT Owlet	3.2168 of 5 stars	$5.29 +0.9%	$15.00 +183.8%	-40.4%	$154.44M	$114.41M	N/A	114

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, STIM, FOCL, OWLT, and ZJYL

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to Neuronetics?

Summary

How does Envoy Medical compare to FocalTherics?

Summary

How does Envoy Medical compare to Owlet?

Summary

How does Envoy Medical compare to Jin Medical International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, STIM, FOCL, OWLT, and ZJYL

How does Envoy Medical compare to Vivani Medical?

Is VANI or COCH more profitable?

Which has more risk & volatility, VANI or COCH?

Does the media refer more to VANI or COCH?

Which has higher earnings and valuation, VANI or COCH?

Do analysts prefer VANI or COCH?

Do institutionals & insiders hold more shares of VANI or COCH?

Summary

How does Envoy Medical compare to Neuronetics?

Do institutionals & insiders believe in STIM or COCH?

Which has more volatility & risk, STIM or COCH?

Do analysts prefer STIM or COCH?

Is STIM or COCH more profitable?

Does the media refer more to STIM or COCH?

Which has stronger earnings and valuation, STIM or COCH?

Summary

How does Envoy Medical compare to FocalTherics?

Do analysts recommend COCH or FOCL?

Is COCH or FOCL more profitable?

Which has stronger earnings and valuation, COCH or FOCL?

Which has more volatility and risk, COCH or FOCL?

Do institutionals and insiders hold more shares of COCH or FOCL?

Does the media favor COCH or FOCL?

Summary

How does Envoy Medical compare to Owlet?

Does the media favor OWLT or COCH?

Which has preferable valuation and earnings, OWLT or COCH?

Which has more risk and volatility, OWLT or COCH?

Do insiders and institutionals have more ownership in OWLT or COCH?

Is OWLT or COCH more profitable?

Do analysts rate OWLT or COCH?

Summary

How does Envoy Medical compare to Jin Medical International?

Which has more volatility & risk, ZJYL or COCH?

Do analysts rate ZJYL or COCH?

Which has preferable valuation and earnings, ZJYL or COCH?

Do insiders & institutionals hold more shares of ZJYL or COCH?

Does the media favor ZJYL or COCH?

Is ZJYL or COCH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools